How can Big Pharma build trust post-pandemic?
14 Jul 2020
How can Big Pharma build trust post-pandemic?

Big Pharma’s reputation has been tarnished over the years by high drug prices and the opioid crisis, but the coronavirus pandemic could be a pivotal moment for the industry. Canvas8 spoke to Oksana Pyzik, a senior teaching fellow at UCL, to find out how pharma firms can regain people's trust.

Oksana Pyzik

Oksana Pyzik is a senior teaching fellow and global engagement lead at the UCL School of Pharmacy and was recently named one of the UK’s top ‘35 Women Under 35’ by Management Today and Accenture. She is also the founder of UCL’s ‘Fight the Fake’ campaign, the leader of the ‘Outbreak! Infectious Disease and Global Citizenship Programme’ at UCL, and a global health advisor and trustee of the Commonwealth Pharmacists Association.

Lottie Hanwell

Lottie Hanwell is a behavioural analyst at Canvas8. She has a degree in English Literature and Spanish, and spends a lot of time thinking, researching and writing about developments in society and culture. On her weekends, she likes to run, read and make a mess in the kitchen.